Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin

Anticancer Research

Volumn 18, Issue 6 B, 1998, Pages 4651-4654

  Alecu, Mihail ^a   Ursaciuc, Cornel ^b   Hãlãlãu, Florin ^b   Coman, Gabriella ^b   Merlevede, Wilfried ^c   Waelkens, Etienne ^c,d   De Witte, Peter ^c  

^a Servan Vodã Clinical Research Center for Dermatology   (Romania)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Basal cell carcinoma; Hypericin; Photodynamic therapy; Squamous cell carcinoma

Indexed keywords

HYPERICIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER REGRESSION; CELL DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TARGETING; EDEMA; EPITHELIUM CELL; ERYTHEMA; FEMALE; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; LIGHT; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION;

EID: 0032438043     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Diwu Z: Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochem Photobiol 61: 529-539, 1995.
2. Reuter HD: Hypericum als pflanzliches antidepressivum. Zeitschrift für Phytotherapie 14: 239-254, 1993.
3. Okpanyi SN, Lidzba H, Scholl BC and Miltenberger HG: Genotoxicität eines standardisierten Hypericum-extraktes. Drug Res 40: 851-855, 1990.
4. Meruelo D, Lavie G and Lavie D: Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci USA 85: 5230-5234, 1988.
5. Couldwell WT, Gopalakrishna R, Hinton DR, He S, Weiss MH, Law RE, and Apuzzo MLJ: Hypericin: a potential antiglioma therapy. Neurosurgery 35: 705-710, 1994.
6. Thomas C and Pardini RS: Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem Photobiol 55: 831-837, 1992.
7. Vandenbogaerde AL, Geboes KR, Cuveele J, Proot P, Agostinis PM, Himpens BE, Merlevede WJ and de Witte PA: Cytotoxic and antineoplastic properties of photosensitized hypericin. Anticancer Res 16: 1611-1618, 1996.
8. Chung PS, Saxton RE, Paiva MB, Rhee C-K, Soudant J, Mathey A, Foote C, and Castro DJ: Hypericin uptake in rabbits and nude mice transplanted with human squamous cell carcinomas: study of a new sensitizer for laser phototherapy. Laryngoscope 104: 1471-1476, 1994.
9. Zhang W, Hinton DR, Surnock AA and Couldwell WT: Tamoxifen and Hypericin sensitivity in Glioma treatment. Neurosurgery 38: 587-591, 1996.
10. Vanderwerf QM, Saxton RE, Chang A, Horton D, Paiva MB, Anderson J, Foote C, Soudant J, Mathey A and Castro DJ: Hypericin: A new laser phototargeting agent for human cancer cells. Laryngoscope 106: 479-483, 1996.
11. de Witte P, Agostinis P, Van Lint J. and Merlevede W, Vandenheede JR: Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin. Biochem Pharmacol 46: 1929-1936, 1993.
12. Velu TJ: Structure, function and transforming potential of the epidermal growth factor receptor. Mol Cell Endocrinol 70: 205-216, 1990.
13. Marks R and Motley RJ: Skin cancer. Recognition and treatment. Drugs 50: 48-61, 1995.
14. Falk H, Meyer J and Oberreiter M: A convenient semi-synthetic route to hypericin. Monatschr Chem 124: 339-341, 1993.
15. Beahrs OH, Henson DE and Hutter RV (eds): Manual for Staging of Cancer, fourth ed. Philadelphia, J.B. Lippincott Company: 1989, pp 133-137.